NCT03983564 is a clinical trial of Cutoff Validation in Obstructive Sleep Apnea, sponsored by Astes.

Who is sponsoring NCT03983564?

NCT03983564 is sponsored by Astes.

What drugs are being tested in NCT03983564?

Interventions in NCT03983564: Cutoff Validation.

What condition does NCT03983564 study?

NCT03983564 studies Obstructive Sleep Apnea.

Is NCT03983564 still recruiting?

NCT03983564 is currently completed. Last updated 24 February 2022.

Last reviewed 2022-02-24 · How we verify

NCT03983564

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Derivation and Validation of a Combination of BOSTON Score and DES-OSA Score for Selection of OSA Patients.

Completed Last updated 24 February 2022

What this trial tests

trial testing Cutoff Validation in Obstructive Sleep Apnea in 100 participants. Completed in 31 October 2021.

Timeline

1 September 2021

Primary endpoint
31 October 2021

31 October 2021

Quick facts

Lead sponsor	Astes
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2021
Primary completion	31 October 2021
Estimated completion	31 October 2021
Sites	1 location across Belgium

Drugs / interventions tested

Cutoff Validation

Conditions studied

Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →

Sponsor

Astes — full company profile →

Who can join

18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Derivation and Validation of a combination of BOSTON score and DES-OSA score to exclude OSA or to confirm OSA in patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting

Other Astes trials

Trials by the same sponsor.

NCT05711329 — Comparison of Methodology Proposed by the SFAR for the Detection by Videoconference of Obstructive Sleep Apnea. · not yet recruiting
NCT05709964 — Comparison of Demographic Data Mentioned by the Patients or Measured by a Physician · completed
NCT05345665 — Comparison of Three Methods of Anesthesia to Achieve a Nerve Block Anesthesia. · NA · completed
NCT03752437 — Comparison of Two Dosages of Heparin Before Extracorporeal Circulation · Phase 4 · completed
NCT03743090 — Influence of Extracorporeal Circulation on the Development of OSA (Obstructive Sleep Apnea) · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03983564 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Astes
Last refreshed: 24 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03983564.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing